Cargando…

Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review

This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.

Detalles Bibliográficos
Autores principales:	Yeung, Kai, Bloudek, Lisa, Ding, Yao, Sullivan, Sean D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856524/ https://www.ncbi.nlm.nih.gov/pubmed/36484998 http://dx.doi.org/10.1001/jamahealthforum.2022.4631

Ejemplares similares

The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
por: Synnott, Patricia G., et al.
Publicado: (2020)

Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model
por: Bloudek, Lisa, et al.
Publicado: (2016)

The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Pandey, Rajshree, et al.
Publicado: (2021)

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
por: Mattingly, T. Joseph, et al.
Publicado: (2018)

The benefits of more government interference in prescription drug pricing
por: Houser, Ryan S.
Publicado: (2022)

Saving energy in residential buildings: the role of energy pricing
por: Ewald, Jens, et al.
Publicado: (2021)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Survey data on energy-saving policies, energy price, crisis and household energy-saving behavior
por: Nguyen, Tung Thanh, et al.
Publicado: (2023)

Economic Value of Medical Institutions
por: Jamal-Ud-Din,
Publicado: (1931)

Will science save us?
Publicado: (2020)

International reference pricing for prescription drugs: a landscape analysis
por: Rand, Leah Z, et al.
Publicado: (2021)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Crowdsourcing Black Market Prices For Prescription Opioids
por: Dasgupta, Nabarun, et al.
Publicado: (2013)

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription
por: Reilly, Thomas J, et al.
Publicado: (2017)

The political economics of cancer drug discovery and pricing
por: Taylor, David G.
Publicado: (2020)

What does the Consumer Price Index for prescription drugs really measure?
por: Cleeton, David L., et al.
Publicado: (1992)

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019)

Resetting Prices: Estimating the Effect of Tuition Reset Policies on Institutional Finances and Enrollment
por: Ward, James Dean, et al.
Publicado: (2022)

Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology
por: Bloudek, Brian, et al.
Publicado: (2022)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs
por: Shin, Gyeongseon, et al.
Publicado: (2022)

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
por: Garrison, Louis P., et al.
Publicado: (2017)

Energy Pricing: Economics and Principles
por: Conkling, Roger L
Publicado: (2011)

Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases
por: Dickson, Sean
Publicado: (2020)

Estimation of Value-Based Price for 48 High-Technology Medical Devices
por: Hyeraci, Giulia, et al.
Publicado: (2023)

Estimation of Relative Economic Weights of Hanwoo Carcass Traits Based on Carcass Market Price
por: Choy, Yun Ho, et al.
Publicado: (2012)

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008)

Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
por: Żelewski, Paweł, et al.
Publicado: (2022)

Save Us from Our Friends
Publicado: (1891)

Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)

Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
por: Rajagopalan, Krithika, et al.
Publicado: (2018)

The Economics of Viagra Revisited: The Price Is Right
por: Agochukwu-Mmonu, Nnenaya, et al.
Publicado: (2021)

Retail pharmacy prescription medicines’ availability, prices and affordability in Eswatini
por: Shambira, Garikai, et al.
Publicado: (2021)

Cancer drugs: high price, uncertain value
por: Cohen, Deborah
Publicado: (2017)

Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines
por: Cassier, Maurice
Publicado: (2021)

Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
por: Lin, John K., et al.
Publicado: (2022)

Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
por: Shahriar, Arman A., et al.
Publicado: (2021)

Evaluation of Health Plan Member Use of an Online Prescription Drug Price Comparison Tool
por: Carroll, Norman V., et al.
Publicado: (2010)

Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration
por: Sullivan, Helen W., et al.
Publicado: (2016)

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ga6soap9llepjkpjnh8ladsqh1